Stemgent, a ReproCELL Group Company and Transposagen Biopharmaceuticals Enter into a Service Partnership Agreement Providing Genetically Engineered Stem Cells

Stemgent, Inc., A ReproCELL Group Company (Cambridge, Massachusetts, U.S.A) and Transposagen Biopharmaceuticals Inc. (Lexington, Kentucky, USA) announced they have entered into a partnership agreement enabling the development of genetically engineered induced pluripotent stem cells (iPSC) services for pharmaceutical, biotechnology, academic and government organizations. 

Read More